Target Healthcare REIT
Target Healthcare REIT
THRL
LSE
90.90
GBX
-0.98%
About
Target Healthcare REIT plc is a United Kingdom-based real estate investment trust. The Company’s investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long leasehold care homes that are let to care home operators, and other healthcare assets in the United Kingdom.
Its portfolio includes Chawley Grove, Roden Hall, The Oaks, Goldwell Manor, Woodland View, and The Manor. The Company’s portfolio comprised 94 properties let to 33 tenants. The Company invests in a portfolio of care homes, predominantly in the United Kingdom, which are let to care home operators on full repairing and insuring leases.
It provides fit-for-purpose real estate for the long term to care providers who demonstrate operational capabilities. The Company’s investment manager and alternative investment fund manager is Target Fund Managers Limited..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 1.7M |
| Three Month Average Volume | 23.5M |
| High Low | |
| Fifty-Two Week High | 0.889 GBX |
| Fifty-Two Week Low | 0.704 GBX |
| Fifty-Two Week High Date | 04 Jan 2024 |
| Fifty-Two Week Low Date | 30 Oct 2023 |
| Price and Volume | |
| Current Price | 0.82 GBX |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 1.02% |
| Thirteen Week Relative Price Change | 0.49% |
| Twenty-Six Week Relative Price Change | -5.85% |
| Fifty-Two Week Relative Price Change | -1.01% |
| Year-to-Date Relative Price Change | -11.96% |
| Price Change | |
| One Day Price Change | -1.68% |
| Thirteen Week Price Change | 1.61% |
| Twenty-Six Week Price Change | 3.02% |
| Five Day Price Change | -3.64% |
| Fifty-Two Week Price Change | 11.11% |
| Year-to-Date Price Change | -4.98% |
| Month-to-Date Price Change | -1.68% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 1.05574 GBX |
| Book Value Per Share (Most Recent Quarter) | 1.07226 GBX |
| Tangible Book Value Per Share (Last Fiscal Year) | 1.05574 GBX |
| Tangible Book Value Per Share (Most Recent Quarter) | 1.07226 GBX |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 0.09196 GBX |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.10923 GBX |
| Revenue Per Share (Trailing Twelve Months) | 0.10926 GBX |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 0.04986 GBX |
| Dividend Per Share (Trailing Twelve Months) | 0.04566 GBX |
| Dividend Per Share (5 Year) | 0.05467 GBX |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.0106 GBX |
| Excluding Extraordinary Items (Trailing Twelve Months) | 0.09411 GBX |
| Normalized (Last Fiscal Year) | -0.01041 GBX |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.0106 GBX |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 0.09411 GBX |
| Including Extraordinary Items (Last Fiscal Year) | -0.0106 GBX |
| Including Extraordinary Items (Trailing Twelve Months) | 0.09411 GBX |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.02477 GBX |
| Cash Per Share (Most Recent Quarter) | 0.02843 GBX |
| Cash Flow Per Share (Last Fiscal Year) | -99999.99 GBX |
| Cash Flow Per Share (Trailing Twelve Months) | -99999.99 GBX |
| Free Cash Flow Per Share (Trailing Twelve Months) | 0.0003 GBX |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -15 |
| Cash Flow Revenue (Trailing Twelve Months) | 0 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 86.12% |
| Pretax Margin (Last Fiscal Year) | -9.70% |
| Pretax Margin (5 Year) | 56.86% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 99.73% |
| Gross Margin (Trailing Twelve Months) | 49.48% |
| Gross Margin (5 Year) | 99.83% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 5.26% |
| Operating Margin (Trailing Twelve Months) | 102.15% |
| Operating Margin (5 Year) | 67.98% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -9.70% |
| Net Profit Margin (Trailing Twelve Months) | 86.12% |
| Net Profit Margin (5 Year) | 56.86% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -0.03% |
| Tangible Book Value (5 Year) | 12.80% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 0.06% |
| Revenue Growth (3 Year) | 19.02% |
| Revenue Change (Trailing Twelve Months) | -5.07% |
| Revenue Per Share Growth | 1.70% |
| Revenue Growth (5 Year) | 15.24% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | 28.75% |
| Dividends | |
| Dividend Growth (3 Year) | -4.15% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 190.02% |
| EPS Change (Trailing Twelve Months) | 1,647.86% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | 19.70% |
| EBITDA (5 Year Interim) | 18.05% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 2.8K |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 232.2M |
| Net Debt (Last Fiscal Year) | 211.7M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 8 |
| Price to Sales (Trailing Twelve Months) | 8 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 9 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 9 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 17 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 9 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 9 |
| Dividends | |
| Dividend Yield (5 Year) | 5.24% |
| Dividend Yield | 6.97% |
| Current Dividend Yield | 5.57% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 35 |
| Long Term Debt to Equity (Most Recent Quarter) | 38 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | 60.10% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | -100,000 |
| Quick Ratio (Most Recent Quarter) | -100,000 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -10,609,000 |
| Free Cash Flow (Trailing Twelve Months) | 183.0K |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 1 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 35 |
| Total Debt to Equity (Most Recent Quarter) | 38 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -0.70% |
| Return on Assets (Trailing Twelve Months) | 6.30% |
| Return on Assets (5 Year) | 4.16% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -0.97% |
| Return on Equity (Trailing Twelve Months) | 8.91% |
| Return on Equity (5 Year) | 5.52% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -0.72% |
| Return on Investment (Trailing Twelve Months) | 6.44% |
| Return on Investment (5 Year) | 4.26% |